Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 967.42B, Eli Lilly(LLY) trades at $1,019.00. The stock has a price-to-earnings ratio of 50.71 and currently yields dividends of 56.6%.
During the trading session on 2025-11-17, Eli Lilly(LLY) shares reached a daily high of $1,032.14 and a low of $998.30. At a current price of $1,019.00, the stock is +2.1% higher than the low and still -1.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 4.72M, versus its average volume of 5.24M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,033.62 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,033.62 and a low of $623.78.
LLY News
Something big is happening in healthcare, as pharma stocks have recently rallied on breakthrough AI developments that could reshape the entire industry. The He...
Eli Lilly has signed an agreement with ABL Biotech for access to the South Korean biotech's Grabody platform to develop bispecific antibodies that is worth up t...
Hedge funds appear to be rebuilding their defensive playbook, and perhaps the clearest tell is a subtle but broad rotation into heavyweight healthcare names. Re...
Analyst ratings
74%
of 31 ratingsMore LLY News
The stock of pharmaceutical company Eli Lilly (LLY) is down 1% on Nov. 17 after news broke that rival Novo Nordisk (NVO) has lowered the direct-to-consumer pric...
Novo Nordisk (NVO) undercut Eli Lilly (LLY) and the Trump administration on Monday, slashing the cash price of its drugs Wegovy and Ozempic to just $349 a month...
North America Barron's Take Eli Lilly Could Be Next Company to Split Its Stock Stock splits bring in new investors in. Netflix, just days away from splitting, i...
Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more aggressive push to regain U.S. market share...
Danish drugmaker Novo Nordisk (NVO) announced that introductory doses of blockbuster weight loss drugs Wegovy and Ozempic will be available for U.S. cash-pay pr...
Investors will be watching what Trump makes happen. Don't look now, but the costs of America's beloved weight loss drugs are about to come down. Way down. At l...
Drugs for weight loss and diabetes are taking Eli Lilly to new heights. The $1 trillion club in the stock market is exclusive. Only 10 companies currently make...
